Universidad Veracruzana, Facultad de Medicina Veterinaria y Zootecnia, Miguel Ángel de Quevedo s/n, Esq. Yáñez. C.P., 91710, Veracruz, Ver, Mexico.
Theriogenology. 2020 Jan 1;141:168-172. doi: 10.1016/j.theriogenology.2019.09.018. Epub 2019 Sep 13.
This study evaluated embryo production after superovulation (SO) with a reduced number of FSH applications and increased eCG dose in 26 Bos taurus × Bos indicus donors. On Day 0, donors received an intravaginal device (CIDR) with 1.9 g of progesterone plus 2.5 mg of estradiol benzoate and 50 mg of progesterone via IM. On Day 4, donors were randomly allotted to one of three SO treatments: 1) 455 IU of Folltropin +400 IU of eCG (n = 9), 2) 350 IU of Folltropin +600 IU of eCG (n = 9), and 3) 500 IU of Pluset + 600 IU of eCG (n = 8). In treatment 455 IU of Folltropin +400 IU of eCG, donors received eight IM Folltropin injections in decreasing dose 12 h apart from Day 4 to Day 7. On Day 6, at the same time as the Folltropin, donors received via IM 25 mg of dinoprost tromethamine (PGF). On Day 7, the CIDR was removed, and together with the Folltropin, donors received 200 IU of eCG via IM. In treatment 350 IU of Folltropin +600 IU of eCG, donors received four IM Folltropin injections in decreasing dose 12 h apart on Days 4 and 5. On Day 6, donors received via IM 600 IU of eCG in the morning and two doses of 25 mg of PGF 12 h apart. On Day 7, the CIDR was removed. Donors from treatment 500 IU of Pluset +600 IU of eCG received four IM Pluset injections in decreasing dose 12 h apart on Days 4 and 5. On Day 6, donors received via IM 600 IU of eCG in the morning and two doses of 25 mg of PGF 12 h apart. On Day 7, the CIDR was removed. In the morning of Day 8, donors from the three treatments received 0.25 mg of GnRH via IM. Artificial insemination was performed on Day 8 (pm) and Day 9 (am). Embryos were collected on Day 15. Variables evaluated were number of CL before embryo collection, number of structures recovered, transferable embryos, degenerate embryos and unfertilized oocytes, recovery rate, and viability rate. There was no difference in any variable among treatments (P > 0.05). In conclusion, replacement of four Folltropin or Pluset injections from a conventional eight FSH-injection SO protocol, by a single injection of 600 IU of eCG, is a good alternative to reduce donor handling without decreasing yield of transferable embryos.
本研究评估了在 26 头荷斯坦公牛×印度瘤牛供体中,通过减少 FSH 应用次数和增加 eCG 剂量来进行超数排卵(SO)后的胚胎生产情况。在第 0 天,供体接受阴道内装置(CIDR),其中含有 1.9 克孕激素加 2.5 毫克苯甲酸雌二醇和 50 毫克孕激素肌内注射。第 4 天,供体随机分为三组 SO 处理之一:1)455IU 的 Folltropin+400IU 的 eCG(n=9),2)350IU 的 Folltropin+600IU 的 eCG(n=9),和 3)500IU 的 Pluset+600IU 的 eCG(n=8)。在 455IU 的 Folltropin+400IU 的 eCG 处理中,供体从第 4 天到第 7 天,每隔 12 小时接受 8 次肌内注射递减剂量的 Folltropin。第 6 天,在 Folltropin 的同时,供体肌内注射 25 毫克地诺前列酮(PGF)。第 7 天,取出 CIDR,并与 Folltropin 一起,供体肌内注射 200IU 的 eCG。在 350IU 的 Folltropin+600IU 的 eCG 处理中,供体在第 4 天和第 5 天每隔 12 小时接受 4 次肌内注射递减剂量的 Folltropin。第 6 天,供体早上肌内注射 600IU 的 eCG,然后每隔 12 小时注射两次 25 毫克 PGF。第 7 天,取出 CIDR。在 500IU 的 Pluset+600IU 的 eCG 处理中,供体在第 4 天和第 5 天每隔 12 小时接受 4 次肌内注射递减剂量的 Pluset。第 6 天,供体早上肌内注射 600IU 的 eCG,然后每隔 12 小时注射两次 25 毫克 PGF。第 7 天,取出 CIDR。第 8 天上午,三组供体都肌内注射 0.25 毫克 GnRH。第 8 天(下午)和第 9 天(上午)进行人工授精。第 15 天收集胚胎。评估的变量包括胚胎收集前的 CL 数量、回收的结构数量、可移植胚胎、退化胚胎和未受精卵、回收率和活力率。在任何变量方面,处理之间均无差异(P>0.05)。总之,用 600IU 的 eCG 替代传统的 8 次 FSH 注射 SO 方案中的 4 次 Folltropin 或 Pluset 注射,是一种减少供体处理次数而不降低可移植胚胎产量的良好替代方法。